Prostate cancer risk calculator for men in Nigeria
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new risk calculator to help doctors in Nigeria find men who may have prostate cancer. If you are a man aged 40 to 79 and visit a participating clinic, you may be asked to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male between 40 and 79 years old.
- You visit a healthcare provider who is part of this study.
- Your provider will use a special risk assessment tool to check your prostate cancer risk.
- You are not part of this study if you are a healthcare provider receiving training.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This project aims to learn about prostate cancer risk and screening needs in Black or African American adults. You may be asked questions and tested as part of determining who might benefit from prostate screening.
This trial offers free prostate cancer education and screening to Black men in Oklahoma who haven't been diagnosed yet. It aims to increase awareness and catch cancer early, but requires using a phone app for 30 days.
This trial compares using an upfront MRI versus a risk calculator to decide who needs a prostate biopsy. It may help men with suspected localized prostate cancer avoid unnecessary biopsies.
This trial aims to raise awareness and screen for prostate cancer in men aged 50 to 69 across the European Union. You may be able to join if you have never been diagnosed with prostate cancer and haven't had a prostate biopsy or MRI in the last six months.
This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.
This trial studies whether a risk assessment can better predict who actually has prostate cancer based on information collected around the biopsy. It may help doctors decide what biopsy findings mean for people with certain PSA (a blood test) results.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.